Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Stem Cell Therapy For Multiple Sclerosis Global Market Report 2025
Download Free Sample Buy Now
Global Stem Cell Therapy For Multiple Sclerosis Market Report 2025

Report Price : $4490.00

Pages : 250

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF
Purchase This Report

Stem Cell Therapy For Multiple Sclerosis Global Market Report 2025

By Type Of Stem Cell (Embryonic Stem Cells, Adult Stem Cells, Induced Pluripotent Stem Cells, Mesenchymal Stem Cells, Hematopoietic Stem Cells), By Treatment Approach (Autologous Stem Cell Therapy, Allogeneic Stem Cell Therapy), By Delivery Method (Intravenous Injection, Intrathecal Injection, Direct Intraspinal Administration), By Application (Relapsing-Remitting Multiple Sclerosis (RRMS), Primary Progressive Multiple Sclerosis (PPMS), Secondary Progressive Multiple Sclerosis (SPMS), Progressive Relapsing Multiple Sclerosis (PRMS)), By End-User (Hospitals, Specialty Clinics, Research Institutes, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Stem Cell Therapy For Multiple Sclerosis Market Overview

• Stem Cell Therapy For Multiple Sclerosis market size has reached to $1.62 billion in 2024

• Expected to grow to $2.89 billion in 2029 at a compound annual growth rate (CAGR) of 12.3%

• Growth Driver: Surge In Multiple Sclerosis Cases Fueling Growth Due To Improving Diagnosis And Awareness

• Market Trend: Advancements In Autologous Mesenchymal Stem Cell Therapies For Multiple Sclerosis

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Stem Cell Therapy For Multiple Sclerosis Market?

Stem cell therapy for multiple sclerosis is a regenerative medical approach that uses stem cells to repair nerve damage and restore immune system balance in patients with multiple sclerosis, an autoimmune disorder that attacks the protective myelin sheath around nerve fibers. The therapy aims to stop disease progression, reduce inflammation, and promote regeneration of damaged nervous tissue.

The main components of stem cell therapy for multiple sclerosis are embryonic stem cells, adult stem cells, induced pluripotent stem cells, mesenchymal stem cells, hematopoietic stem cells. Stem cell therapy for multiple sclerosis using embryonic stem cells involves transplanting pluripotent cells derived from early-stage embryos to repair damaged myelin and promote neural regeneration. The various treatment approach include autologous stem cell therapy, allogeneic stem cell therapy. The delivery method includes intravenous injection, intrathecal injection, direct intraspinal administration. The applications include relapsing-remitting multiple sclerosis (RRMS), primary progressive multiple sclerosis (PPMS), secondary progressive multiple sclerosis (SPMS), progressive relapsing multiple sclerosis (PRMS). The various end-users include hospitals, specialty clinics, research institutes, others.

Stem Cell Therapy For Multiple Sclerosis Market Size and growth rate 2025 to 2029: Graph

What Is The Stem Cell Therapy For Multiple Sclerosis Market Size 2025 And Growth Rate?

The stem cell therapy for multiple sclerosis market size has grown rapidly in recent years. It will grow from $1.62 billion in 2024 to $1.82 billion in 2025 at a compound annual growth rate (CAGR) of 12.6%. The growth in the historic period can be attributed to increasing demand for regenerative medicine, rising prevalence of multiple sclerosis, growing awareness of stem cell therapies, increasing investment in stem cell research, and increasing clinical outcomes supporting stem cell therapy efficacy.

What Is The Stem Cell Therapy For Multiple Sclerosis Market Growth Forecast?

The stem cell therapy for multiple sclerosis market size is expected to see rapid growth in the next few years. It will grow to $2.89 billion in 2029 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to increasing demand for personalized medicine, growing patient preference for minimally invasive treatments, expansion of regenerative therapy centers, increasing insurance coverage for advanced therapies, and rising collaborations between biotech companies and research institutions. Major trends in the forecast period include technological advancements in stem cell delivery methods, developments in gene editing and regenerative techniques, innovation in immunomodulatory therapies, investment in research and development for novel treatments, and advancements in biomaterials for cell therapy.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Stem Cell Therapy For Multiple Sclerosis Market Segmented?

1) By Type Of Stem Cell: Embryonic Stem Cells, Adult Stem Cells, Induced Pluripotent Stem Cells, Mesenchymal Stem Cells, Hematopoietic Stem Cells

2) By Treatment Approach: Autologous Stem Cell Therapy, Allogeneic Stem Cell Therapy

3) By Delivery Method: Intravenous Injection, Intrathecal Injection, Direct Intraspinal Administration

4) By Application: Relapsing-Remitting Multiple Sclerosis (RRMS), Primary Progressive Multiple Sclerosis (PPMS), Secondary Progressive Multiple Sclerosis (SPMS), Progressive Relapsing Multiple Sclerosis (PRMS)

5) By End-User: Hospitals, Specialty Clinics, Research Institutes, Other End-Users

Subsegments:

1) By Embryonic Stem Cells: Inner Cell Mass Cells, Blastocyst Derived Cells, Totipotent Stem Cells

2) By Adult Stem Cells: Bone Marrow Stem Cells, Neural Stem Cells, Tissue Specific Stem Cells

3) By Induced Pluripotent Stem Cells: Reprogrammed Somatic Cells, Patient Derived Cells

4) By Mesenchymal Stem Cells: Adipose Derived Stem Cells, Umbilical Cord Derived Stem Cells, Bone Marrow Derived Stem Cells

5) By Hematopoietic Stem Cells: Peripheral Blood Stem Cells, Bone Marrow Stem Cells, Umbilical Cord Blood Stem Cells

What Is Driving The Stem Cell Therapy For Multiple Sclerosis Market? Surge In Multiple Sclerosis Cases Fueling Growth Due To Improving Diagnosis And Awareness

The increasing prevalence of multiple sclerosis (MS) is expected to contribute significantly to the growth of the stem cell therapy for multiple sclerosis market going forward. Multiple sclerosis is a chronic autoimmune disease that affects the central nervous system by damaging the protective myelin sheath surrounding nerve fibers, leading to impaired communication between the brain and body and causing symptoms such as fatigue, muscle weakness, and vision problems. The rising prevalence of MS is primarily attributed to improved diagnostic capabilities, as advances in medical imaging and heightened awareness enable more accurate and earlier identification of cases, resulting in higher reported numbers. Stem cell therapy for multiple sclerosis aids in repairing damaged myelin, modulating abnormal immune responses, and promoting nerve cell regeneration, thereby helping to reduce symptoms and potentially slow disease progression. For instance, in May 2024, according to a report published by the MS Trust, a UK-based organization, approximately 2.9 million people worldwide are affected by multiple sclerosis, including over 150,000 individuals living with the condition in the UK. Therefore, the increasing prevalence of multiple sclerosis is expected to drive the expansion of the stem cell therapy for multiple sclerosis industry.

Who Are The Major Players In The Global Stem Cell Therapy For Multiple Sclerosis Market?

Major companies operating in the stem cell therapy for multiple sclerosis market are Sana Biotechnology Inc., Century Therapeutics Inc., Reelabs Private Limited, PlacidWay LLC, MedAccess Guarantee Ltd, Celltex Therapeutics Corporation, CELLTEX THERAPEUTICS CORP, BrainStorm Cell Therapeutics Ltd., Athersys Inc., Advancells Dermaceuticals Private Limited, ImStem Biotechnology Inc., NeuroGenesis Bio Inc., Stem Cell Medicine Ltd., Biotherapy International, R3 Stem Cell, Hope Biosciences LLC, FibroBiologics Inc., Global Institute of Stem Cell Therapy and Research Inc., ProgenCell, Stemwell

What Are The Key Trends Of The Global Stem Cell Therapy For Multiple Sclerosis Market? Advancements In Autologous Mesenchymal Stem Cell Therapies For Multiple Sclerosis

Major companies operating in the stem cell therapy for multiple sclerosis market are focusing on developing innovative products, such as adipose-derived mesenchymal stem cells, to enhance the efficacy, safety, and regenerative potential of treatments for patients with relapsing-remitting and progressive forms of multiple sclerosis. Adipose-derived mesenchymal stem cells (ADMSCs) are multipotent stem cells derived from adipose (fat) tissue that can differentiate into multiple cell types and exhibit regenerative and immunomodulatory properties beneficial in treating autoimmune and neurodegenerative diseases such as multiple sclerosis. For instance, in August 2025, Hope Biosciences, LLC, a US-based biopharmaceutical company, introduced its HB-adMSCs therapy, which utilizes adipose-derived mesenchymal stem cells administered through high-dose infusions and repeat dosing over a 32-week period. The therapy combines immunomodulatory and neuroregenerative mechanisms, offering the potential to slow disease progression and repair myelin damage, distinguishing it from conventional immunosuppressive treatments.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Stem Cell Therapy For Multiple Sclerosis Market? Pluri Inc. Partners With Brainstorm Cell Therapeutics Ltd. To Advance Regenerative Therapies

In November 2024, Pluri Inc., an Israel-based biotechnology company, partnered with Brainstorm Cell Therapeutics Ltd. Through this partnership, Pluri Inc. aims to advance the development and commercialization of innovative regenerative therapies in collaboration with Brainstorm Cell Therapeutics Ltd., leveraging their combined expertise to accelerate clinical research and improve treatment outcomes for patients. Brainstorm Cell Therapeutics Ltd. is a US-based biotechnology company that provides stem cell therapy for multiple sclerosis.

What Is The Regional Outlook For The Global Stem Cell Therapy For Multiple Sclerosis Market?

North America was the largest region in the stem cell therapy for multiple sclerosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Stem Cell Therapy For Multiple Sclerosis Market?

The stem cell therapy for multiple sclerosis market includes revenues earned by providing services such as stem cell collection and processing services, cryopreservation and storage services, patient preconditioning services, post-therapy rehabilitation services, and immune system profiling services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Stem Cell Therapy For Multiple Sclerosis Industry?

The stem cell therapy for multiple sclerosis market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the stem cell therapy for multiple sclerosis industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Stem Cell Therapy For Multiple Sclerosis Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $1.82 billion
Revenue Forecast In 2034 $2.89 billion
Growth Rate CAGR of 12.6% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered Type Of Stem Cell, Treatment Approach, Delivery Method, Application, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Sana Biotechnology Inc., Century Therapeutics Inc., Reelabs Private Limited, PlacidWay LLC, MedAccess Guarantee Ltd, Celltex Therapeutics Corporation, CELLTEX THERAPEUTICS CORP, BrainStorm Cell Therapeutics Ltd., Athersys Inc., Advancells Dermaceuticals Private Limited, ImStem Biotechnology Inc., NeuroGenesis Bio Inc., Stem Cell Medicine Ltd., Biotherapy International, R3 Stem Cell, Hope Biosciences LLC, FibroBiologics Inc., Global Institute of Stem Cell Therapy and Research Inc., ProgenCell, Stemwell
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Stem Cell Therapy For Multiple Sclerosis Market Characteristics

3. Stem Cell Therapy For Multiple Sclerosis Market Trends And Strategies

4. Stem Cell Therapy For Multiple Sclerosis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Stem Cell Therapy For Multiple Sclerosis Growth Analysis And Strategic Analysis Framework

5.1. Global Stem Cell Therapy For Multiple Sclerosis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Stem Cell Therapy For Multiple Sclerosis Market Growth Rate Analysis

5.4. Global Stem Cell Therapy For Multiple Sclerosis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Stem Cell Therapy For Multiple Sclerosis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Stem Cell Therapy For Multiple Sclerosis Total Addressable Market (TAM)

6. Stem Cell Therapy For Multiple Sclerosis Market Segmentation

6.1. Global Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Embryonic Stem Cells

Adult Stem Cells

Induced Pluripotent Stem Cells

Mesenchymal Stem Cells

Hematopoietic Stem Cells

6.2. Global Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Autologous Stem Cell Therapy

Allogeneic Stem Cell Therapy

6.3. Global Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Intravenous Injection

Intrathecal Injection

Direct Intraspinal Administration

6.4. Global Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Relapsing-Remitting Multiple Sclerosis (RRMS)

Primary Progressive Multiple Sclerosis (PPMS)

Secondary Progressive Multiple Sclerosis (SPMS)

Progressive Relapsing Multiple Sclerosis (PRMS)

6.5. Global Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Specialty Clinics

Research Institutes

Other End-Users

6.6. Global Stem Cell Therapy For Multiple Sclerosis Market, Sub-Segmentation Of Embryonic Stem Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Inner Cell Mass Cells

Blastocyst Derived Cells

Totipotent Stem Cells

6.7. Global Stem Cell Therapy For Multiple Sclerosis Market, Sub-Segmentation Of Adult Stem Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Bone Marrow Stem Cells

Neural Stem Cells

Tissue Specific Stem Cells

6.8. Global Stem Cell Therapy For Multiple Sclerosis Market, Sub-Segmentation Of Induced Pluripotent Stem Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Reprogrammed Somatic Cells

Patient Derived Cells

6.9. Global Stem Cell Therapy For Multiple Sclerosis Market, Sub-Segmentation Of Mesenchymal Stem Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Adipose Derived Stem Cells

Umbilical Cord Derived Stem Cells

Bone Marrow Derived Stem Cells

6.10. Global Stem Cell Therapy For Multiple Sclerosis Market, Sub-Segmentation Of Hematopoietic Stem Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Peripheral Blood Stem Cells

Bone Marrow Stem Cells

Umbilical Cord Blood Stem Cells

7. Stem Cell Therapy For Multiple Sclerosis Market Regional And Country Analysis

7.1. Global Stem Cell Therapy For Multiple Sclerosis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Stem Cell Therapy For Multiple Sclerosis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Stem Cell Therapy For Multiple Sclerosis Market

8.1. Asia-Pacific Stem Cell Therapy For Multiple Sclerosis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Stem Cell Therapy For Multiple Sclerosis Market

9.1. China Stem Cell Therapy For Multiple Sclerosis Market Overview

9.2. China Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Stem Cell Therapy For Multiple Sclerosis Market

10.1. India Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Stem Cell Therapy For Multiple Sclerosis Market

11.1. Japan Stem Cell Therapy For Multiple Sclerosis Market Overview

11.2. Japan Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Stem Cell Therapy For Multiple Sclerosis Market

12.1. Australia Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Stem Cell Therapy For Multiple Sclerosis Market

13.1. Indonesia Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Stem Cell Therapy For Multiple Sclerosis Market

14.1. South Korea Stem Cell Therapy For Multiple Sclerosis Market Overview

14.2. South Korea Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Stem Cell Therapy For Multiple Sclerosis Market

15.1. Western Europe Stem Cell Therapy For Multiple Sclerosis Market Overview

15.2. Western Europe Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Stem Cell Therapy For Multiple Sclerosis Market

16.1. UK Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Stem Cell Therapy For Multiple Sclerosis Market

17.1. Germany Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Stem Cell Therapy For Multiple Sclerosis Market

18.1. France Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Stem Cell Therapy For Multiple Sclerosis Market

19.1. Italy Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Stem Cell Therapy For Multiple Sclerosis Market

20.1. Spain Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Stem Cell Therapy For Multiple Sclerosis Market

21.1. Eastern Europe Stem Cell Therapy For Multiple Sclerosis Market Overview

21.2. Eastern Europe Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Stem Cell Therapy For Multiple Sclerosis Market

22.1. Russia Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Stem Cell Therapy For Multiple Sclerosis Market

23.1. North America Stem Cell Therapy For Multiple Sclerosis Market Overview

23.2. North America Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Stem Cell Therapy For Multiple Sclerosis Market

24.1. USA Stem Cell Therapy For Multiple Sclerosis Market Overview

24.2. USA Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Stem Cell Therapy For Multiple Sclerosis Market

25.1. Canada Stem Cell Therapy For Multiple Sclerosis Market Overview

25.2. Canada Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Stem Cell Therapy For Multiple Sclerosis Market

26.1. South America Stem Cell Therapy For Multiple Sclerosis Market Overview

26.2. South America Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Stem Cell Therapy For Multiple Sclerosis Market

27.1. Brazil Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Stem Cell Therapy For Multiple Sclerosis Market

28.1. Middle East Stem Cell Therapy For Multiple Sclerosis Market Overview

28.2. Middle East Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Stem Cell Therapy For Multiple Sclerosis Market

29.1. Africa Stem Cell Therapy For Multiple Sclerosis Market Overview

29.2. Africa Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Stem Cell Therapy For Multiple Sclerosis Market Competitive Landscape And Company Profiles

30.1. Stem Cell Therapy For Multiple Sclerosis Market Competitive Landscape

30.2. Stem Cell Therapy For Multiple Sclerosis Market Company Profiles

30.2.1. Sana Biotechnology Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Century Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Reelabs Private Limited Overview, Products and Services, Strategy and Financial Analysis

30.2.4. PlacidWay LLC Overview, Products and Services, Strategy and Financial Analysis

30.2.5. MedAccess Guarantee Ltd Overview, Products and Services, Strategy and Financial Analysis

31. Stem Cell Therapy For Multiple Sclerosis Market Other Major And Innovative Companies

31.1. Celltex Therapeutics Corporation

31.2. CELLTEX THERAPEUTICS CORP

31.3. BrainStorm Cell Therapeutics Ltd.

31.4. Athersys Inc.

31.5. Advancells Dermaceuticals Private Limited

31.6. ImStem Biotechnology Inc.

31.7. NeuroGenesis Bio Inc.

31.8. Stem Cell Medicine Ltd.

31.9. Biotherapy International

31.10. R3 Stem Cell

31.11. Hope Biosciences LLC

31.12. FibroBiologics Inc.

31.13. Global Institute of Stem Cell Therapy and Research Inc.

31.14. ProgenCell

31.15. Stemwell

32. Global Stem Cell Therapy For Multiple Sclerosis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Stem Cell Therapy For Multiple Sclerosis Market

34. Recent Developments In The Stem Cell Therapy For Multiple Sclerosis Market

35. Stem Cell Therapy For Multiple Sclerosis Market High Potential Countries, Segments and Strategies

35.1 Stem Cell Therapy For Multiple Sclerosis Market In 2029 - Countries Offering Most New Opportunities

35.2 Stem Cell Therapy For Multiple Sclerosis Market In 2029 - Segments Offering Most New Opportunities

35.3 Stem Cell Therapy For Multiple Sclerosis Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Stem Cell Therapy For Multiple Sclerosis Market, Sub-Segmentation Of Embryonic Stem Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Stem Cell Therapy For Multiple Sclerosis Market, Sub-Segmentation Of Adult Stem Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Stem Cell Therapy For Multiple Sclerosis Market, Sub-Segmentation Of Induced Pluripotent Stem Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Stem Cell Therapy For Multiple Sclerosis Market, Sub-Segmentation Of Mesenchymal Stem Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Stem Cell Therapy For Multiple Sclerosis Market, Sub-Segmentation Of Hematopoietic Stem Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Stem Cell Therapy For Multiple Sclerosis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Global Stem Cell Therapy For Multiple Sclerosis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Asia-Pacific, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: Asia-Pacific, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: China, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: China, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: India, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: India, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Japan, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Japan, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Australia, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Australia, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Indonesia, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Indonesia, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: South Korea, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: South Korea, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Western Europe, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Western Europe, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: UK, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: UK, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Germany, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Germany, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: France, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: France, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Italy, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Italy, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Spain, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Spain, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Eastern Europe, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Eastern Europe, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Russia, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: Russia, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: North America, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: North America, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: USA, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: USA, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Canada, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Canada, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: South America, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: South America, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Brazil, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Brazil, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Middle East, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Middle East, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Africa, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Africa, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 81: Sana Biotechnology Inc. Financial Performance
  • Table 82: Century Therapeutics Inc. Financial Performance
  • Table 83: Reelabs Private Limited Financial Performance
  • Table 84: PlacidWay LLC Financial Performance
  • Table 85: MedAccess Guarantee Ltd Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Stem Cell Therapy For Multiple Sclerosis Market, Sub-Segmentation Of Embryonic Stem Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Stem Cell Therapy For Multiple Sclerosis Market, Sub-Segmentation Of Adult Stem Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Stem Cell Therapy For Multiple Sclerosis Market, Sub-Segmentation Of Induced Pluripotent Stem Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Stem Cell Therapy For Multiple Sclerosis Market, Sub-Segmentation Of Mesenchymal Stem Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Stem Cell Therapy For Multiple Sclerosis Market, Sub-Segmentation Of Hematopoietic Stem Cells, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Stem Cell Therapy For Multiple Sclerosis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Global Stem Cell Therapy For Multiple Sclerosis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Asia-Pacific, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: Asia-Pacific, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: China, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: China, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: India, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: India, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Japan, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Japan, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Australia, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Australia, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Indonesia, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Indonesia, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: South Korea, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: South Korea, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Western Europe, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Western Europe, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: UK, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: UK, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Germany, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Germany, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: France, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: France, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Italy, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Italy, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Spain, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Spain, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Eastern Europe, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Eastern Europe, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Russia, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: Russia, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: North America, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: North America, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: USA, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: USA, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Canada, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Canada, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: South America, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: South America, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Brazil, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Brazil, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Middle East, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Middle East, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Type Of Stem Cell, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Africa, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Treatment Approach, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Africa, Stem Cell Therapy For Multiple Sclerosis Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 81: Sana Biotechnology Inc. Financial Performance
  • Figure 82: Century Therapeutics Inc. Financial Performance
  • Figure 83: Reelabs Private Limited Financial Performance
  • Figure 84: PlacidWay LLC Financial Performance
  • Figure 85: MedAccess Guarantee Ltd Financial Performance

Emerging Trends and Growth Drivers in the Pediatric Dental Market Through 2029

Read More About Emerging Trends and Growth Drivers in the Pediatric Dental Market Through 2029

Competitive and Market Trend Analysis of Pharmaceutical Cold Chain Packaging Industry Through 2029

Read More About Competitive and Market Trend Analysis of Pharmaceutical Cold Chain Packaging Industry Through 2029

Key Market Drivers, Trends, and Forecast for the Global Pharmaceutical Warehousing Industry

Read More About Key Market Drivers, Trends, and Forecast for the Global Pharmaceutical Warehousing Industry

2025 Analysis: Opportunities and Risks in the Evolving Precision Genomic Testing Market

Read More About 2025 Analysis: Opportunities and Risks in the Evolving Precision Genomic Testing Market

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Read More About A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Read More About A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Stem Cell Therapy Global Market Report 2025 – By Type (Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy), By Cell Source (Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells), By Application ...

View Report

Human Embryonic Stem Cells Global Market Report 2025 – By Type (Totipotent Stem Cells, Pluripotent Stem Cells, Unipotent Stem Cells), By Product (Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering, Tox...

View Report

Stem Cell Manufacturing Global Market Report 2025 – By Product (Consumables, Instruments, Stem Cell Lines), By Application (Research Applications, Clinical Application, Cell and Tissue Banking Applications), By End User ...

View Report

Autologous Stem Cell And Non-Stem Cell Based Therapies Global Market Report 2025 – By Type (Autologous Stem Cells, Autologous Non-Stem Cells, Other Types), By Application (Cancer, Neurodegenerative Disorders, Cardiovascu...

View Report

Stem Cell Assay Global Market Report 2025 – By Type (Cell Viability And Toxicity Assays, Cell Apoptosis Assays, Cell Function Assays, Cell Identification Assays, Isolation And Purification Assays, Cell Differentiation As...

View Report

Cell Regeneration Medicine Global Market Report 2025 – By Product (Therapeutics, Tools, Banks, Services), By Therapeutic Category (Dermatology, Musculoskeletal, Immunology And Inflammation, Oncology, Cardiovascular, Opht...

View Report

Atrophic Glossitis Treatment Global Market Report 2025 – By Treatment Type (Medications, Topical Treatments, Nutritional Supplements, Oral Care Products), By Symptoms (Inflammation, Discoloration, Itching, Burning Tongue...

View Report

Cell Therapy Technologies Global Market Report 2025 – By Product (Consumables, Equipment, Systems And Software), By Cell Type (T-Cells, Stem Cells, Other Cells), By Process (Cell Processing, Cell Preservation, Distributi...

View Report

Frequently Asked Questions

Stem cell therapy for multiple sclerosis is a regenerative medical approach that uses stem cells to repair nerve damage and restore immune system balance in patients with multiple sclerosis, an autoimmune disorder that attacks the protective myelin sheath around nerve fibers. The therapy aims to stop disease progression, reduce inflammation, and promote regeneration of damaged nervous tissue. For further insights on this market, request a sample here

The market major growth driver - Surge In Multiple Sclerosis Cases Fueling Growth Due To Improving Diagnosis And Awareness. For further insights on this market, request a sample here

The stem cell therapy for multiple sclerosis market size has grown rapidly in recent years. It will grow from $1.62 billion in 2024 to $1.82 billion in 2025 at a compound annual growth rate (CAGR) of 12.6%. The growth in the historic period can be attributed to increasing demand for regenerative medicine, rising prevalence of multiple sclerosis, growing awareness of stem cell therapies, increasing investment in stem cell research, and increasing clinical outcomes supporting stem cell therapy efficacy. The stem cell therapy for multiple sclerosis market size is expected to see rapid growth in the next few years. It will grow to $2.89 billion in 2029 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to increasing demand for personalized medicine, growing patient preference for minimally invasive treatments, expansion of regenerative therapy centers, increasing insurance coverage for advanced therapies, and rising collaborations between biotech companies and research institutions. Major trends in the forecast period include technological advancements in stem cell delivery methods, developments in gene editing and regenerative techniques, innovation in immunomodulatory therapies, investment in research and development for novel treatments, and advancements in biomaterials for cell therapy. For further insights on this market, request a sample here

The stem cell therapy for multiple sclerosis market covered in this report is segmented –
1) By Type Of Stem Cell: Embryonic Stem Cells, Adult Stem Cells, Induced Pluripotent Stem Cells, Mesenchymal Stem Cells, Hematopoietic Stem Cells
2) By Treatment Approach: Autologous Stem Cell Therapy, Allogeneic Stem Cell Therapy
3) By Delivery Method: Intravenous Injection, Intrathecal Injection, Direct Intraspinal Administration
4) By Application: Relapsing-Remitting Multiple Sclerosis (RRMS), Primary Progressive Multiple Sclerosis (PPMS), Secondary Progressive Multiple Sclerosis (SPMS), Progressive Relapsing Multiple Sclerosis (PRMS)
5) By End-User: Hospitals, Specialty Clinics, Research Institutes, Other End-Users Subsegments:
1) By Embryonic Stem Cells: Inner Cell Mass Cells, Blastocyst Derived Cells, Totipotent Stem Cells
2) By Adult Stem Cells: Bone Marrow Stem Cells, Neural Stem Cells, Tissue Specific Stem Cells
3) By Induced Pluripotent Stem Cells: Reprogrammed Somatic Cells, Patient Derived Cells
4) By Mesenchymal Stem Cells: Adipose Derived Stem Cells, Umbilical Cord Derived Stem Cells, Bone Marrow Derived Stem Cells
5) By Hematopoietic Stem Cells: Peripheral Blood Stem Cells, Bone Marrow Stem Cells, Umbilical Cord Blood Stem Cells For further insights on this market, request a sample here

North America was the largest region in the stem cell therapy for multiple sclerosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the stem cell therapy for multiple sclerosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the stem cell therapy for multiple sclerosis market are Sana Biotechnology Inc., Century Therapeutics Inc., Reelabs Private Limited, PlacidWay LLC, MedAccess Guarantee Ltd, Celltex Therapeutics Corporation, CELLTEX THERAPEUTICS CORP, BrainStorm Cell Therapeutics Ltd., Athersys Inc., Advancells Dermaceuticals Private Limited, ImStem Biotechnology Inc., NeuroGenesis Bio Inc., Stem Cell Medicine Ltd., Biotherapy International, R3 Stem Cell, Hope Biosciences LLC, FibroBiologics Inc., Global Institute of Stem Cell Therapy and Research Inc., ProgenCell, Stemwell . For further insights on this market, request a sample here.

Major trends in this market include Advancements In Autologous Mesenchymal Stem Cell Therapies For Multiple Sclerosis. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Stem Cell Therapy For Multiple Sclerosis Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon